Search

How can multi-column chromatography support companies as they set their sights on intensified bioprocesses?

The COVID-19 pandemic exposed weaknesses in pharma supply chains. It’s time to address these.

This 6 episode miniseries will take listeners behind the scenes of a range of projects at the Drugs for Neglected Diseases initiative

Is commercializing gene therapy manufacturing an unsolvable problem? We ask an expert on the frontlines.

Medicare publishes policy for amyloid mAbs and Alzheimer’s disease. It’s not good news for Aduhelm.

Get excited, because the results are in! Find out who won the 2022 Innovation Awards

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

We sat down to talk shop with Novo Nordisk Executive Vice President Ludovic Helfgott

One decade behind the EU, biosimilars are arriving in the US. What can we expect? Jeff Baldetti from Cardinal Health has a few ideas.

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.